Address
Form of work
SalaryJob Details
Do you want to feel inspired every day? We are future-focused, and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you.
We are looking for an enthusiastic individual to work as a Senior Training Officer to support GMP manufacturing, to ensure the training requirements for new and existing employees within manufacturing teams are coordinated and fully implemented to meet the regulatory requirements.
Our manufacturing team is a critical part of Oxford Biomedica’s operations. We produce multiple clinical and commercial lentiviral vector-based gene therapy products across seven cleanroom suites in Oxford.
Your responsibilities in this role would be:
Responsible for the induction of new employees within the manufacturing department and other specific activities regarding their inductions, such as presentations and practical trainings in the clean room.
Ensure all operators are within their required qualification status at all times. Schedule and perform initial qualifications and requalification’s required for GMP manufacturing in timely manner.
Required to review and follow up the revisions of documentation such as qualifications protocols, in collaboration with QC department to ensure qualifications are finalized in timely manner.
To assist other members of the team / departmental managers in keeping the staff training records up to date with all relevant documentation and evidence required to prove competency of the staff.
Delivery of various training sessions to the departmental staff as required, in the office environment and/or in the clean room facilities.
Ensure existing training modules and materials are being up to date and assist in updates, creation, and improvement of the materials/training methods.
What’s in it for you:
Highly competitive reward packages
Wellbeing programmes
Development opportunities
A 35-hour working week
Welcoming, friendly, supportive colleagues
A diverse and inclusive working environment
Our values are: Deliver Innovation, Be Inspiring and Have Integrity
State of the art laboratory and manufacturing facilities
We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you.
No agencies please
Profile description:
We are looking for:
Minimum education to A level or equivalent ideally with sciences or possess sufficient industry experience
Proven experience performing practical training sessions for individuals and groups.
Experience in delivering Training in a GMP environment.
Knowledge of GMP manufacturing and regulatory standards would be an advantage.
Previous manufacturing experience in an MHRA /FDA regulated environment would be an advantage.
Excellent verbal and written communication skills.
Confident in delivering effective presentations.
Strong attention to detail.
Proficient in use of Microsoft Office applications
Ability to plan and prioritise.
About Us:
We are a quality and innovation-led cell and gene therapy CDMO with a mission to enable our clients to deliver life changing therapies to patients around the world.
Our innovative solutions and proven expertise allow our clients in the biotech and biopharma industry, to deliver life-saving therapies to reach even more patients.
The success of cell and gene therapy products transforms outcomes for millions of people suffering from some of the world’s worst diseases and medical conditions.
Collaborate. Contribute. Change lives.
Closing date for applications is Friday 26th January 2024.
We offer:
Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
